1 |
STERN J, PIER J, LITONJUA A A. Asthma epidemiology and risk factors [J]. Semin Immunopathol, 2020, 42(1): 5-15.
|
2 |
ANDREA M, SUSANNA B, FRANCESCA N, et al. The emerging role of type 2 inflammation in asthma [J]. Expert Rev Clin Immunol, 2021, 17(1): 63-71.
|
3 |
TJOTA M Y, SPERLING A I. Distinct dendritic cell subsets actively induce Th2 polarization [J]. Curr Opin Immunol, 2014, 31: 44-50.
|
4 |
HAN M, HU R, MA J, et al. Fas Signaling in Dendritic Cells Mediates Th2 Polarization in HDM-Induced Allergic Pulmonary Inflammation [J]. Front Immunol, 2018, 9: 3045.
|
5 |
HAN M, MA J, OUYANG S, et al. The kinase p38alpha functions in dendritic cells to regulate Th2-cell differentiation and allergic inflammation [J]. Cell Mol Immunol, 2022, 19(7): 805-819.
|
6 |
CONEJERO L, KHOUILI S C, MARTINEZ-CANO S, et al. Lung CD103+ dendritic cells restrain allergic airway inflammation through IL-12 production [J]. JCI Insight, 2017,2(10):e90420.
|
7 |
ARDAIN A, MARAKALALA M J, LESLIE A. Tissue-resident innate immunity in the lung [J]. Immunology, 2020, 159(3): 245-256.
|
8 |
CHAIRAKAKI A D, SARIDAKI M I, PYRILLOU K, et al. Plasmacytoid dendritic cells drive acute asthma exacerbations [J]. J Allergy Clin Immunol, 2018, 142(2): 542-556 e512.
|
9 |
DEMEDTS I K, BRACKE K R, MAES T, et al. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms [J]. Am J Respir Cell Mol Biol, 2006, 35(3): 387-393.
|
10 |
EL-GAMMAL A, OLIVERIA J P, HOWIE K, et al. Allergen-induced Changes in Bone Marrow and Airway Dendritic Cells in Subjects with Asthma [J]. Am J Respir Crit Care Med, 2016, 194(2): 169-177.
|
11 |
AZID N A, AHMAD S, BOER J C, et al. A profile of TNFR2(+) regulatory T cells and CD103(+) dendritic cells in the peripheral blood of patients with asthma [J]. Hum Immunol, 2020, 81(10-11): 634-643.
|
12 |
SUN S, GU Y, WANG J, et al. Effects of Fatty Acid Oxidation and Its Regulation on Dendritic Cell-Mediated Immune Responses in Allergies: An Immunometabolism Perspective [J]. J Immunol Res, 2021, 2021: 7483865.
|
13 |
KRATCHMAROV R, VIRAGOVA S, KIM M J, et al. Metabolic control of cell fate bifurcations in a hematopoietic progenitor population [J]. Immunol Cell Biol, 2018, 96(8): 863-871.
|
14 |
YIN X, ZENG W, WU B, et al. PPARalpha Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction [J]. Cell Rep, 2020, 33(3): 108278.
|
15 |
ZHANG C, YUE C, HERRMANN A, et al. STAT3 Activation-Induced Fatty Acid Oxidation in CD8(+) T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth [J]. Cell Metab, 2020, 31(1): 148-161 e145.
|
16 |
MALINARICH F, DUAN K, HAMID R A, et al. High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells [J]. J Immunol, 2015, 194(11): 5174-5186.
|
17 |
HSIEH M H, JAN R L, WU L S, et al. Lactobacillus gasseri attenuates allergic airway inflammation through PPARgamma activation in dendritic cells [J]. J Mol Med (Berl), 2018, 96(1): 39-51.
|
18 |
NIEVES W, HUNG L Y, ONISKEY T K, et al. Myeloid-Restricted AMPKalpha1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection [J]. J Immunol, 2016, 196(11): 4632-4640.
|
19 |
GAUVREAU G M, SEHMI R, AMBROSE C S, et al. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma [J]. Expert Opin Ther Targets, 2020, 24(8): 777-792.
|
20 |
HUANG L, ZHANG X, WANG M, et al. Exosomes from Thymic Stromal Lymphopoietin-Activated Dendritic Cells Promote Th2 Differentiation through the OX40 Ligand [J]. Pathobiology, 2019, 86(2-3): 111-117.
|
21 |
NGUYEN K D, VANICHSARN C, NADEAU K C. TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway [J]. Allergy Asthma Clin Immunol, 2010, 6(1): 4.
|
22 |
HONG H, LIAO S, CHEN F, et al. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation [J]. Allergy, 2020, 75(11): 2794-2804.
|
23 |
LI Y, WANG W, LV Z, et al. Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease [J]. J Immunol, 2018, 200(7): 2253-2262.
|
24 |
WANG W, AN G, LI Y, et al. IL-33 amplifies airways inflammation in a murine surrogate of asthma putatively via activation of dendritic cells [J]. Cell Immunol, 2021, 366: 104395.
|
25 |
PENG B, SUN L, ZHANG M, et al. Role of IL-25 on Eosinophils in the Initiation of Th2 Responses in Allergic Asthma [J]. Front Immunol, 2022, 13: 842500.
|
26 |
XU M, DONG C. IL-25 in allergic inflammation [J]. Immunol Rev, 2017, 278(1): 185-191.
|
27 |
HONGJIA L, CAIQING Z, DEGAN L, et al. IL-25 promotes Th2 immunity responses in airway inflammation of asthmatic mice via activation of dendritic cells [J]. Inflammation, 2014, 37(4): 1070-1077.
|
28 |
ZECH A, AYATA C K, PANKRATZ F, et al. MicroRNA-155 modulates P2R signaling and Th2 priming of dendritic cells during allergic airway inflammation in mice [J]. Allergy, 2015, 70(9): 1121-1129.
|
29 |
TANG H, JIANG H, ZHENG J, et al. MicroRNA-106b regulates pro-allergic properties of dendritic cells and Th2 polarisation by targeting early growth response-2 in vitro [J]. Int Immunopharmacol, 2015, 28(2): 866-874.
|
30 |
HUANG L, WANG M, CHEN Z, et al. MiR-138 regulates dendritic cells mediated Th2-type immune response by regulating the OX40L expression in asthma [J]. Int J Clin Exp Pathol, 2017, 10(11): 10979-10988.
|
31 |
KIDD C D, THOMPSON P J, BARRETT L, et al. Histone Modifications and Asthma. The Interface of the Epigenetic and Genetic Landscapes [J]. Am J Respir Cell Mol Biol, 2016, 54(1): 3-12.
|
32 |
KASINATH V, BECK C, SAUER P, et al. JARID2 and AEBP2 regulate PRC2 in the presence of H2AK119ub1 and other histone modifications [J]. Science, 2021,371(6527):eabc3393.
|